Dren Bio Closes 350 Million Dollar Financing
Dren Bio announced an oversubscribed $350 million private financing on 29 October to advance CD94 antibody dibotatug through late-stage development in rare cytotoxic blood cancers. The round is new capital, but no Series label…
